Navigation Links
PAREXEL Appoints Leading Central Nervous System Experts to Its Global Clinical Pharmacology Business
Date:4/2/2008

isit http://www.PAREXEL.com.

This release contains "forward-looking" statements regarding future results and events. For this purpose, any statements contained herein that are not statements of historical fact may be deemed forward-looking statements. Without limiting the foregoing, the words "believes," "anticipates," "plans," "expects," "intends," "appears," "estimates," "projects," "targets," and similar expressions are also intended to identify forward-looking statements. The forward-looking statements in this release involve a number of risks and uncertainties. The Company's actual future results may differ significantly from the results discussed in the forward-looking statements contained in this release. Important factors that might cause such a difference include, but are not limited to, risks associated with: actual operating performance; actual expense savings and other operating improvements resulting from recent restructurings; the loss, modification, or delay of contracts which would, among other things, adversely impact the Company's recognition of revenue included in backlog; the Company's dependence on certain industries and clients; the Company's ability to win new business, manage growth and costs, and attract and retain employees; the Company's ability to complete additional acquisitions and to integrate newly acquired businesses or enter into new lines of business; the impact on the Company's business of government regulation of the drug, medical device and biotechnology industry; consolidation within the pharmaceutical industry and competition within the biopharmaceutical services industry; the potential for significant liability to clients and third parties; the potential adverse impact of health care reform; and the effects of exchange rate fluctuations and other international economic, political, and other risks. Such factors and others are discussed more fully in the section entitled
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. PAREXEL International Expands Relationship with Synchron Research in India and Divests Bioanalytical Laboratory in France
2. PAREXEL Announces Date of Third Quarter Fiscal Year 2008 Earnings Release and Conference Call
3. PAREXEL Appoints Leading Biopharmaceutical Marketing Expert Jacque Fisher to Medical Communications Services Executive Team
4. PAREXEL International to Present at Lehman Brothers 11th Annual Global Healthcare Conference
5. PAREXEL International to Present at Raymond James 29th Annual Institutional Investors Conference
6. PAREXEL to Present Leading Insights Regarding Key Industry Topics at 20th Annual Drug Information Association EuroMeeting
7. PAREXEL International Announces 2-For-1 Stock Split
8. PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results
9. PAREXEL Names Biopharmaceutical Industry Executive Eduard E. Holdener to Board of Directors
10. PAREXEL Announces Date of Second Quarter Fiscal Year 2008 Earnings Release and Conference Call
11. PAREXEL Appoints Charles A. Stevens as Vice President/General Manager of Health Policy and Strategic Reimbursement and Strengthens Capabilities

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Health care employment grew by 29,000 jobs... show consistent growth during the U.S. recession....n trouble, and health systems are coming closer to... of just administrators. , ...ent continued growing in October despite the shedd...
(Date:11/24/2009)...24/PRNewswire/--BlueMarbleEnergyCorp.announcedtoda...ity(OPDA)wererecentlyawarded$2millionbyWashingtonS...aprivate/publicpartnershiptoconstructthestate,sfir...A. ,, "Thisinvestmentwillsignificantlyspeedthed...oLincolnCounty,"saidBlueMarbleEnergyCEOKellyOgilvi...
(Date:11/24/2009)....24,2009/PRNewswire-FirstCall/--ArenaPharmaceutica...nyisscheduledtopresentatthePiperJaffray21stAnnualH...ernTime(8:30a.m.PacificTime)attheNewYorkPalaceHote...ExecutiveOfficer,isscheduledtoprovideanoverviewoft...eryprograms. ,, Aliveaudiowebcastofthepresentat...
(Date:11/24/2009)...24/PRNewswire-FirstCall/--CellTherapeutics,Inc.(CT...tAnnualPiperJaffrayHealthCareConference.Theconfere...tel. ,, CTIwillpresentonTuesday,December1at11:0...astofCTI,spresentationwillbeavailableat www.cellth...fterwards. , ,PiperJaffrayHealthCareConference,Ne...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2
...., March 31 Watson Pharmaceuticals, Inc. (NYSE: ..., announced today that the United States District ...Watson,s generic version of Concerta (methylphenid...ot infringe United States Patent No. 6,919,373 (th.... The opinion, dated March 30, 2009, was issued b...
...ologics announces the filing of two important prov...h 31 Quantum Immunologics, Inc. (QI), a Florida-b... has recently filed two provisional patent applica...py. , , The company,s research is focused on the...cifically, iLRP - immature Laminin Receptor Protei...
...March 31 ArunA Biomedical, Inc., a leader in huma...today that it has been awarded a Department of Def...r utilizing its human stem cell technology. , ,...080819/CLTU003LOGO ) , , The company will furth...lular model for use in a prototype biosensor devel...
Other Biology Technology:Delaware Court Rules That Watson Does Not Infringe Patent Related to Generic Version of Concerta(R) and Declares Patent Invalid 2Immunotherapy-Based Provisional Patents Mark Significant Discovery 2Immunotherapy-Based Provisional Patents Mark Significant Discovery 3ArunA Biomedical Awarded Department of Defense Contract to Further Develop Environmental Biosensor for National Security 2
(Date:11/23/2009)... University of Alabama at Birmingham (UAB) researc...ing medical conditions (co-morbidity) do not expla...mericans compared to Caucasians who also have colo... Cancer , a journal of the American Cancer Societ... co-morbidity are independent predictors of poor s...
(Date:11/23/2009)... existed for 360 million years and survived when t...hreatening to make many of them extinct, according...ogy Today . , The fungus, Batrachochytrium den...waves of amphibian extinctions in Central America ...cts over 350 amphibian species by penetrating thei...
(Date:11/23/2009)...ronmental irritants such as air pollution and ciga...lished today in the American Journal of Respirato... study, from Imperial College London and the Unive... the lungs that can trigger coughing when a person...ey suggest that their findings may ultimately lead...
Breaking Biology News(10 mins):Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Research reveals exactly how coughing is triggered by environmental irritants 2AEterna Zentaris Receives US 245 5 Million from Institutional Investors 14577 1AEterna Zentaris Receives US 245 5 Million from Institutional Investors 14577 2AEterna Zentaris Receives US 245 5 Million from Institutional Investors 14577 3Gauze based NPWT Capable of Achieving Same Treatment Goals as Foam based NPWT 5665 1Gauze based NPWT Capable of Achieving Same Treatment Goals as Foam based NPWT 5665 2Gauze based NPWT Capable of Achieving Same Treatment Goals as Foam based NPWT 5665 3Gauze based NPWT Capable of Achieving Same Treatment Goals as Foam based NPWT 5665 4Governor Rendell Says Hundreds of Jobs Coming to York County as Medical Device Manufacturer Prepares to Expand 5662 1Governor Rendell Says Hundreds of Jobs Coming to York County as Medical Device Manufacturer Prepares to Expand 5662 2Governor Rendell Says Hundreds of Jobs Coming to York County as Medical Device Manufacturer Prepares to Expand 5662 3
...to resist the effects of cheap and popular antivir...tionary tale about U.S. plans to use the antiviral...ction in humans, scientists say. , Researchers an...nza strains to document where and when the virus d...called adamantanes and how far resistant strains s...
...xposed to low temperatures develop more blood vess...t more quickly, according to a new study from Karo...w to control blood vessel development in humans in...th of fat cells and their metabolism depend on oxy...egulate the amount of body fat in order, for inst...
...more efficient that exploits the inertia of a wind...d speed variation, according to research published...s . , Wind power is being touted as a clean and i...he wind is intermittent and so the power output of...smooth these power fluctuations usually involve th...
Other Biology News:Study: Excessive use of antiviral drugs could aid deadly flu 2Study: Excessive use of antiviral drugs could aid deadly flu 3Study: Excessive use of antiviral drugs could aid deadly flu 4Study: Excessive use of antiviral drugs could aid deadly flu 5Tilting at wind farms 2
...g and positioning system is designed for applicati...canned with high velocity and high resolution. It ...positioners with conventional leadscrew drives. Th...rated, non-contact, zero-friction, voice-coil actu...
Microarray Spotting Solution for Silane Coated Slides from Sigma-Aldrich
...y wells in the base hold 10 l of water to maintain...dges of the coverslip. The watertight seal elimina...ber can be used with either constant temperature w...S number is a new product number, created to easil...
Eppendorf MicroDissector from Eppendorf North America
Biology Products: